Literature DB >> 23354650

microRNA expression profiling and bioinformatic analysis of dengue virus‑infected peripheral blood mononuclear cells.

Yiming Qi1, Ying Li, Lin Zhang, Junqi Huang.   

Abstract

Dengue virus (DENV) causes self‑limiting dengue fever (DF), severe dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). It is generally considered that cytokine storm leads to the increased plasma leakage characteristic of DHF/DSS. In the present study, peripheral blood mononuclear cells (PBMCs) were isolated from blood samples of healthy volunteers and infected with DENV serotype 2 (DENV2). Culture supernatants of DENV2‑infected and -uninfected PBMCs were analyzed using a human cytokine array. Between a 6‑12 h post‑infection, levels of CCL5, IL‑6 and IL‑8 were markedly elevated, while those of TNF‑α decreased. Total RNA isolated from these PBMCs was analyzed by human miRNA microarray to identify differentially expressed microRNAs (miRNAs). Quantitative reverse transcription polymerase chain reaction was used to validate 11 upregulated and 4 downregulated miRNAs. Sanger mibase, miRanda and TargetScan were used to identify 261 common predicted genes. Databases were used to identify homologous sequences on mRNAs of putative target genes that may be directly bound by the miRNAs identified. We found that cytokines and epigenetic regulators may be putative target genes of these miRNAs. Using ingenuity pathway analysis, we noted that canonical pathways, including biological regulation, may be modulated by these miRNAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354650     DOI: 10.3892/mmr.2013.1288

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  25 in total

Review 1.  RNA viruses and microRNAs: challenging discoveries for the 21st century.

Authors:  Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

2.  The emerging role of epigenetics in the immune response to vaccination and infection: a systematic review.

Authors:  Samantha Bannister; Nicole L Messina; Boris Novakovic; Nigel Curtis
Journal:  Epigenetics       Date:  2020-03-17       Impact factor: 4.528

3.  Altered microRNA expression signature in Chikungunya-infected mammalian fibroblast cells.

Authors:  Deepti Parashar; Mandar S Paingankar; Ashwini More; Poonam Patil; Sarika Amdekar
Journal:  Virus Genes       Date:  2018-06-05       Impact factor: 2.332

4.  Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication.

Authors:  Andrii Slonchak; Rory P Shannon; Gabor Pali; Alexander A Khromykh
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

5.  MicroRNA 573 Rescues Endothelial Dysfunction during Dengue Virus Infection under PPARγ Regulation.

Authors:  Shefali Banerjee; Chin Wei Xin; Justin Jang Hann Chu
Journal:  J Virol       Date:  2022-03-23       Impact factor: 6.549

Review 6.  A glance at subgenomic flavivirus RNAs and microRNAs in flavivirus infections.

Authors:  Lorena Bavia; Ana Luiza Pamplona Mosimann; Mateus Nóbrega Aoki; Claudia Nunes Duarte Dos Santos
Journal:  Virol J       Date:  2016-05-28       Impact factor: 4.099

Review 7.  Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs.

Authors:  Amanda L Aloia; Alexander M Abraham; Claudine S Bonder; Stuart M Pitson; Jillian M Carr
Journal:  Mediators Inflamm       Date:  2015-11-02       Impact factor: 4.711

Review 8.  The miRNA world of polyomaviruses.

Authors:  Ole Lagatie; Luc Tritsmans; Lieven J Stuyver
Journal:  Virol J       Date:  2013-08-28       Impact factor: 4.099

Review 9.  Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?

Authors:  John F Arboleda; Silvio Urcuqui-Inchima
Journal:  Adv Virol       Date:  2016-05-11

10.  Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.

Authors:  Xiaoxi Ouyang; Xin Jiang; Dayong Gu; Yaou Zhang; S K Kong; Chaoxin Jiang; Weidong Xie
Journal:  Int J Med Sci       Date:  2016-02-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.